ANL
Price
$10.10
Change
-$0.16 (-1.56%)
Updated
Jun 18 closing price
Capitalization
650.42M
48 days until earnings call
Intraday BUY SELL Signals
HYPD
Price
$3.45
Change
-$0.08 (-2.27%)
Updated
Jun 18 closing price
Capitalization
52.29M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANL vs HYPD

ANL vs HYPD Comparison Chart in %
View a ticker or compare two or three
VS
ANL vs. HYPD commentary
Jun 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a Hold and HYPD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2026
Stock price -- (ANL: $10.26 vs. HYPD: $3.53)
Brand notoriety: ANL and HYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 24% vs. HYPD: 488%
Market capitalization -- ANL: $650.42M vs. HYPD: $52.29M
ANL [@Biotechnology] is valued at $650.42M. HYPD’s [@Biotechnology] market capitalization is $52.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.63B to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 0 FA rating(s) are green whileHYPD’s FA Score has 1 green FA rating(s).

  • ANL’s FA Score: 0 green, 5 red.
  • HYPD’s FA Score: 1 green, 4 red.
According to our system of comparison, HYPD is a better buy in the long-term than ANL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANL’s TA Score shows that 3 TA indicator(s) are bullish while HYPD’s TA Score has 5 bullish TA indicator(s).

  • ANL’s TA Score: 3 bullish, 5 bearish.
  • HYPD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HYPD is a better buy in the short-term than ANL.

Price Growth

ANL (@Biotechnology) experienced а -2.01% price change this week, while HYPD (@Biotechnology) price change was +40.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.61%. For the same industry, the average monthly price growth was +8.78%, and the average quarterly price growth was +2225.89%.

Reported Earning Dates

ANL is expected to report earnings on Aug 06, 2026.

HYPD is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (+2.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANL($650M) has a higher market cap than HYPD($52.3M). ANL YTD gains are higher at: 622.535 vs. HYPD (-0.843). HYPD has higher annual earnings (EBITDA): -31.79M vs. ANL (-49.89M). ANL has more cash in the bank: 98M vs. HYPD (7.38M). HYPD has less debt than ANL: HYPD (9.07M) vs ANL (39.5M). ANL has higher revenues than HYPD: ANL (5M) vs HYPD (1.04M).
ANLHYPDANL / HYPD
Capitalization650M52.3M1,243%
EBITDA-49.89M-31.79M157%
Gain YTD622.535-0.843-73,874%
P/E RatioN/AN/A-
Revenue5M1.04M479%
Total Cash98M7.38M1,328%
Total Debt39.5M9.07M435%
FUNDAMENTALS RATINGS
HYPD: Fundamental Ratings
HYPD
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANLHYPD
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ANL
Daily Signal:
Gain/Loss:
HYPD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLVIX72.12N/A
N/A
JHancock Fundamental Large Cap Core I
PIUCX7.95-0.03
-0.38%
Federated Hermes International Equity C
MVALX45.88-0.47
-1.01%
Meridian Contrarian Legacy
MXNZX8.32-0.11
-1.30%
Empower S&P Mid Cap 400® Index Instl
UIVIX12.37-0.22
-1.75%
MFS Intrinsic Equity I

ANL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANL has been loosely correlated with MSLE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANL jumps, then MSLE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
+2.09%
MSLE - ANL
40%
Loosely correlated
+1.74%
REVB - ANL
33%
Loosely correlated
+11.34%
SER - ANL
23%
Poorly correlated
-2.94%
HYPD - ANL
23%
Poorly correlated
+8.95%
MOLN - ANL
23%
Poorly correlated
-0.51%
More

HYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYPD has been loosely correlated with KYNB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPD jumps, then KYNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPD
1D Price
Change %
HYPD100%
+8.95%
KYNB - HYPD
48%
Loosely correlated
N/A
ACXP - HYPD
36%
Loosely correlated
N/A
INKT - HYPD
34%
Loosely correlated
+3.39%
CTXR - HYPD
33%
Poorly correlated
-0.31%
QNTM - HYPD
31%
Poorly correlated
+9.07%
More